Hsin-Hui Chiu1, Mei-Hwan Wu2, Hui-Chi Chen3, Feng-Yu Kao4, San-Kuei Huang4. 1. Department of Pediatrics, Taipei Medical University, Taipei, Taiwan; Department of Pediatrics, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan. 2. Department of Pediatrics, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan. Electronic address: wumh@ntu.edu.tw. 3. Genomics Research Center, Academia Sinica, Taipei, Taiwan. 4. Taiwan Bureau of National Health Insurance, Taipei, Taiwan.
Abstract
OBJECTIVE: To explore the current epidemiological profile of Marfan syndrome in a general population. PATIENTS AND METHODS: Patients who had received a diagnosis of Marfan syndrome were identified from the Taiwan National Health Insurance database records from January 1, 2000, through December 31, 2012 (average population size, 22,765,535). Cardiovascular events and interventions were identified by using the respective International Classification of Diseases codes. RESULTS: We identified 2329 patients (58% men) with Marfan syndrome. The overall prevalence was 10.2 (95% CI, 9.8-10.7) per 100,000 individuals, with peaks at the age of 15 to 19, 10 to 14, and 20 to 24 years. The minimal birth incidence of 23.3 (95% CI, 21.7-23.3) per 100,000 individuals was estimated in those aged 20 to 29 years. The average annual mortality was 0.23% (69 deaths), mostly owing to cardiac causes (including dissection and sudden death in 40 patients, 58%). Aortic dissection occurred in 226 patients (10%; 61% men) at a mean age of 36.6±10.7 years. The probability of freedom from dissection was 99%, 80%, and 66% at the age of 20, 40, and 50 years, respectively. Of the 69 deaths and 226 dissections during the follow-up period, more than half of the cases occurred before the age of 40 years. Cardiovascular intervention was performed in 360 patients, with early mortality being higher in the emergent operation group (8%) than in the elective group (0%). CONCLUSION: From this national cohort study, the minimal birth incidence was 23.3 per 100,000 individuals, that is, possibly 1 patient with Marfan syndrome per 4286 people. Despite medical advances, aortic dissection still occurs in about one-tenth of the patients and carries a high mortality risk. Early diagnosis and timely medical interventions are warranted.
OBJECTIVE: To explore the current epidemiological profile of Marfan syndrome in a general population. PATIENTS AND METHODS: Patients who had received a diagnosis of Marfan syndrome were identified from the Taiwan National Health Insurance database records from January 1, 2000, through December 31, 2012 (average population size, 22,765,535). Cardiovascular events and interventions were identified by using the respective International Classification of Diseases codes. RESULTS: We identified 2329 patients (58% men) with Marfan syndrome. The overall prevalence was 10.2 (95% CI, 9.8-10.7) per 100,000 individuals, with peaks at the age of 15 to 19, 10 to 14, and 20 to 24 years. The minimal birth incidence of 23.3 (95% CI, 21.7-23.3) per 100,000 individuals was estimated in those aged 20 to 29 years. The average annual mortality was 0.23% (69 deaths), mostly owing to cardiac causes (including dissection and sudden death in 40 patients, 58%). Aortic dissection occurred in 226 patients (10%; 61% men) at a mean age of 36.6±10.7 years. The probability of freedom from dissection was 99%, 80%, and 66% at the age of 20, 40, and 50 years, respectively. Of the 69 deaths and 226 dissections during the follow-up period, more than half of the cases occurred before the age of 40 years. Cardiovascular intervention was performed in 360 patients, with early mortality being higher in the emergent operation group (8%) than in the elective group (0%). CONCLUSION: From this national cohort study, the minimal birth incidence was 23.3 per 100,000 individuals, that is, possibly 1 patient with Marfan syndrome per 4286 people. Despite medical advances, aortic dissection still occurs in about one-tenth of the patients and carries a high mortality risk. Early diagnosis and timely medical interventions are warranted.
Authors: Dianna M Milewicz; Alan C Braverman; Julie De Backer; Shaine A Morris; Catherine Boileau; Irene H Maumenee; Guillaume Jondeau; Arturo Evangelista; Reed E Pyeritz Journal: Nat Rev Dis Primers Date: 2021-09-02 Impact factor: 65.038
Authors: Yskert von Kodolitsch; Julie De Backer; Helke Schüler; Peter Bannas; Cyrus Behzadi; Alexander M Bernhardt; Mathias Hillebrand; Bettina Fuisting; Sara Sheikhzadeh; Meike Rybczynski; Tilo Kölbel; Klaus Püschel; Stefan Blankenberg; Peter N Robinson Journal: Appl Clin Genet Date: 2015-06-16
Authors: Alex Pitcher; Jonathan Emberson; Ronald V Lacro; Lynn A Sleeper; Mario Stylianou; Lynn Mahony; Gail D Pearson; Maarten Groenink; Barbara J Mulder; Aeilko H Zwinderman; Julie De Backer; Anne M De Paepe; Eloisa Arbustini; Guliz Erdem; Xu Yu Jin; Marcus D Flather; Michael J Mullen; Anne H Child; Alberto Forteza; Arturo Evangelista; Hsin-Hui Chiu; Mei-Hwan Wu; George Sandor; Ami B Bhatt; Mark A Creager; Richard B Devereux; Bart Loeys; J Colin Forfar; Stefan Neubauer; Hugh Watkins; Catherine Boileau; Guillaume Jondeau; Harry C Dietz; Colin Baigent Journal: Am Heart J Date: 2015-02-12 Impact factor: 4.749
Authors: Kristian A Groth; Hanne Hove; Kasper Kyhl; Lars Folkestad; Mette Gaustadnes; Niels Vejlstrup; Kirstine Stochholm; John R Østergaard; Niels H Andersen; Claus H Gravholt Journal: Orphanet J Rare Dis Date: 2015-12-02 Impact factor: 4.123